Charles Mellerio

Charles Mellerio

Auto-generated profile, based on publicly available information

Charles Mellerio

INSERM UMR 1266, Institute of Psychiatry and Neuroscience of Paris (IPNP), Paris; Neuroradiology Department, GHU Paris Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2010 in Neurology
Verified
Journal Article
Closed access
PDF file
FCF. Chassoux
F. Chassoux
SRS. Rodrigo
S. Rodrigo
FSF. Semah
F. Semah
FBF. Beuvon
F. Beuvon
ELE. Landre
E. Landre
CCC. Chiron
C. Chiron
Objective: To determine the diagnostic accuracy and prognostic value of 18FDG-PET in a recent series of patients operated for intractable partial epilepsy associated with histologically proven Taylor-type focal cortical dysplasia (TTFCD) and negative MRI. Methods: Of 23 consecutive patients (12 male, 7–38 years old) with negative 1.5-Tesla MRI, 10 exhibited subtle nonspecific abnormalities (e.g., unusual sulcus depth or gyral pattern) and the 13 others had strictly normal MRI. FDG-PET was analyzed both visually after coregistration on MRI and using SPM5 software. Metabolic data were compared with the epileptogenic zone (EZ) determined by stereo-EEG (SEEG) and surgical outcome. Results: Visual PET analysis disclosed a focal or regional hypometabolism in 18 cases (78%) corresponding to a single gyrus (n = 9) or a larger cortical region (n = 9). PET/MRI coregistration detected a partially hypometabolic gyrus in 4 additional cases. SPM5 PET analysis (n = 18) was concordant with visual analysis in 13 cases. Location of PET abnormalities was extratemporal in all cases, involving eloquent cortex in 15 (65%). Correlations between SEEG, PET/MRI, and histologic findings (n = 20) demonstrated that single hypometabolic gyri (n = 11) corresponded to EZ and TTFCD, which was localized at the bottom of the sulcus. Larger hypometabolic areas (n = 9) also included the EZ and the dysplastic cortex but were more extensive. Following limited cortical resection (mean follow-up 4 years), seizure freedom without permanent motor deficit was obtained in 20/23 patients (87%). Conclusions: 18FDG-PET coregistered with MRI is highly sensitive to detect TTFCD and greatly improves diagnosis and surgical prognosis of patients with negative MRI.

5 January 2012 in Epilepsia
Verified
Journal Article
Open access
PDF file
FCFrancine Chassoux
Francine Chassoux
ELElisabeth Landré
Elisabeth Landré
CMCharles Mellerio
Charles Mellerio
BTBaris Turak
Baris Turak
MMMichael W. Mann
Michael W. Mann
BDBertrand Devaux
Bertrand Devaux
Summary: Purpose: Type II focal cortical dysplasia (TTFCD), a highly epileptogenic lesion with severe epilepsy curable by surgery, is missed by magnetic resonance imaging (MRI) in about one third of cases. Little is known about the electroclinical presentation in these MRI‐negative patients and a poor surgical outcome is frequently reported. We compared the clinical and neurophysiologic features in MRI‐negative and MRI‐positive cases in order to better identify candidates for surgery.Methods: Among 62 consecutive TTFCD patients (38 male, 24 female; 7–52 years old; 22 children) operated for intractable epilepsy, 25 (40%) presented negative MRI findings. We compared the history of epilepsy; the type, frequency, and distribution of seizures; neurologic examination cognitive and psychiatric impairment; interictal‐ictal electroencephalography (EEG) and stereo‐EEG (SEEG) data, fluorodeoxyglucose positron emission tomography (FDG‐PET) data, neuropathologic findings; and surgical outcome in the MRI‐negative and the MRI‐positive groups.Key Findings: Severe partial epilepsy beginning in childhood, high seizure frequency including status epilepticus, stereotyped seizures suggestive of precise brain localization, extratemporal location and functional area involvement were characteristic and similarly found in both groups. On EEG, pseudorhythmic activity was found in about 40% of patients in each group. SEEG recordings demonstrated the typical pattern characterizing TTFCD in both groups. FDG‐PET had a localization value in 84% of the MRI‐negative cases and helped to delineate the dysplastic cortex in 65% of the MRI‐positive cases. The combination of imaging and neurophysiologic data allowed us to perform safe and restricted resections, limited to a single gyrus in more than half of all cases. In addition, we were able to avoid invasive monitoring in most MRI‐positive cases and even in some selected MRI‐negative cases. The proportion of patients with a favorable surgical outcome was comparable in both groups (88% in MRI‐negative and 94% in MRI‐positive cases). The main difference between the groups was a significantly higher frequency of sleep‐related epilepsy in the MRI‐negative group (p = 0.028). This phenotypic characteristic provides a new argument for TTFCD in MRI‐negative extratemporal epilepsy.Significance: These results lead us to consider that children or adult patients in whom electroclinical data suggest TTFCD, are highly suitable for surgery, especially for cryptogenic sleep‐related epilepsy.

10 February 2015 in Neurology
Verified
Journal Article
Closed access
GKGrégory Kuchcinski
Grégory Kuchcinski
CMCharles Mellerio
Charles Mellerio
JPJohan Pallud
Johan Pallud
EDEdouard Dezamis
Edouard Dezamis
GTGuillaume Turc
Guillaume Turc
COCatherine Oppenheim
Catherine Oppenheim
To evaluate the accuracy of functional MRI (fMRI) at 3T, as currently used in the preoperative mapping of language areas, compared with direct cortical stimulation (DCS) during awake surgery, in patients with supratentorial gliomas; and to identify clinical, histopathologic,and radiologic factors associated with fMRI/DCS discrepancies. Language mapping with fMRI and DCS of 40 consecutive patients with gliomas(24 low-grade, 16 high-grade) in functional areas were retrospectively analyzed. Three block designed tasks were performed during fMRI (letter word generation, category word generation,semantic association). During awake surgery, eloquent areas were mapped using DCS, blinded to fMRI. A site-by-site comparison of the 2 techniques was performed using a cortical grid. fMRI sensitivity and specificity were calculated using DCS as the reference. Associations of clinical,histopathologic, and radiologic features (including relative cerebral blood volume [rCBV] measured with dynamic susceptibility contrast MRI) with fMRI false-positive and false-negative occurrence were assessed using hierarchical logistic regressions. Of 2,114 stimulated cortical sites, 103 were positive for language during DCS. Sensitivity and specificity of language fMRI combining the 3 tasks reached 37.1% (95% confidence interval [CI] 20.7–57.2) and 83.4% (95% CI 77.1–88.3), respectively. Astrocytoma subtype(odds ratio [OR] 2.50 [1.32–4.76]; p 5 0.007), tumor rCBV ,1.5 (OR 2.17 [1.08–4.35]; p 50.03), higher cortical rCBV (OR 2.22 [1.15–4.17]; p 5 0.02), and distance to tumor .1 cm (OR2.46 [1.82–3.32]; p # 0.001) were independently associated with fMRI false-positive occurrence. There are pitfalls in preoperative fMRI as currently used in preoperative language mapping in glioma patients, made more complicated when high-grade and hyperperfused tumors are evaluated.

15 November 2013 in Epilepsia
Verified
Journal Article
Closed access
PDF file
CMCharles Mellerio
Charles Mellerio
MLMarc‐Antoine Labeyrie
Marc‐Antoine Labeyrie
FCFrancine Chassoux
Francine Chassoux
PRPauline Roca
Pauline Roca
OAOdile Alami
Odile Alami
COCatherine Oppenheim
Catherine Oppenheim

1 July 2013 in Stroke
Verified
Journal Article
Closed access
PDF file
LLLaurence Legrand
Laurence Legrand
ONOlivier Naggara
Olivier Naggara
GTGuillaume Turc
Guillaume Turc
CMCharles Mellerio
Charles Mellerio
PRPauline Roca
Pauline Roca
COCatherine Oppenheim
Catherine Oppenheim
Background and Purpose—: To propose a T2*-MR adaptation of the computed tomography angiography-clot burden score (CBS), and assess its value as predictor of 24-hour recanalization and clinical outcome in anterior circulation stroke treated by intravenous thrombolysis ≤4.5 hours from onset. Methods—: Two independent observers retrospectively analyzed pretreatment T2* images for evaluation of clot burden, using a 10-point scale T2*-CBS. Three points are subtracted for susceptibility vessel sign in the supraclinoid internal carotid artery, 2 points each for susceptibility vessel sign in the proximal and distal part of middle cerebral artery, and 1 point each for susceptibility vessel sign in middle cerebral artery branches (with a maximum of 2 points) and for susceptibility vessel sign in anterior cerebral artery. Associations with 24-hour recanalization and favorable outcome (3-month modified Rankin Scale score, ≤2) were assessed in multivariate analyses. Results—: We analyzed 184 consecutive patients (mean age, 67 years) with median (interquartile range) admission National Institutes of Health Stroke Scale score and onset-to-treatment time of 15 (9–19) and 151 (120–185) minutes, respectively. The intraclass correlation for T2*-CBS between observers was 0.97 (95% confidence interval, 0.97–0.98). In multivariate analyses, T2*-CBS >6 was significantly associated with 24-hour recanalization (adjusted odds ratio, 5.1 [1.9–13.5]; P =0.001) or with favorable outcome (adjusted odds ratio, 4.2 [1.7–10.8]; P =0.003). Conclusions—: T2*-CBS, a new reproducible semiquantitative score adapted from the computed tomography angiography-CBS, is associated with 24-hour recanalization and 3-month outcome after intravenous thrombolysis. This score needs external validation and could be useful to identify poor responders to intravenous thrombolysis.

3 May 2012 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
CMC. Mellerio
C. Mellerio
MLM.-A. Labeyrie
M.-A. Labeyrie
FCF. Chassoux
F. Chassoux
CDC. Daumas-Duport
C. Daumas-Duport
ELE. Landre
E. Landre
COC. Oppenheim
C. Oppenheim
BACKGROUND AND PURPOSE: Type 2 FCD is one of the main causes of drug-resistant partial epilepsy. Its detection by MR imaging has greatly improved surgical outcomes, but it often remains overlooked. Our objective was to determine the prevalence of typical MR imaging criteria for type 2 FCD, to provide a precise MR imaging pattern, and to optimize its detection. MATERIALS AND METHODS: We retrospectively reviewed 1.5T MR imaging of 71 consecutive patients with histologically proved type 2 FCD. The protocol included millimetric 3D T1-weighted, 2D coronal and axial T2-weighted, and 2D or 3D FLAIR images. Two experienced neuroradiologists looked for 6 criteria: cortex thickening, cortical and subcortical signal changes, blurring of the GWM interface, the “transmantle” sign, and gyral abnormalities. The frequency of each sign and their combination were assessed. We compared the delay between epilepsy onset and surgery, taking into account the time of type 2 FCD detection by MR imaging. RESULTS: Only 42 patients (59%) had positive MR imaging findings. In this group, a combination of at least 3 criteria was always found. Subcortical signal changes were constant. Three characteristic signs (cortical thickening, GWM blurring, and transmantle sign) were combined in 64% of patients, indicating that MR imaging can be highly suggestive. However, typical features of type 2 FCD were overlooked on initial imaging in 40% of patients, contributing to a delay in referral for surgical consideration (17 versus 11.5 years when initial MR imaging findings were positive). CONCLUSIONS: A combination of 3 major MR imaging signs allows type 2 FCD to be recognized in clinical practice, thereby enabling early identification of candidates for surgery.